Announcements

LakePharma Announces its GMP Biorepository Facility near Boston is Now Operational, Plans Additional Hiring Learn more 

LakePharma Announces its cGMP microBiomanufacturing Center is Now Operational Learn more 

LakePharma Licenses the Diverse Xoma Fab and scFv Naive Human Phage Display Libraries  Learn more

LakePharma Expands Antibody Center Into New 40,000 sq. ft. San Carlos Building Learn more

LakePharma Announces “New Frontiers in Biologics” for 2018 Protein Engineering Symposium Learn more

LakePharma and Harbour Antibodies Announce Partnership for H2L2 Transgenic Mouse Platform Learn more

About Us

LakePharma is the leading US-based biologics company specializing in antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, bioanalytics and µBIOMANUFACTURING‚Ą† biologics manufacturing services for Phase 1 clinical trials. 

With facilities located in the heart of the San Francisco Bay Area and near the Boston/Cambridge biotech hub, LakePharma has developed numerous in-house technology platforms to provide cost-effective and high quality services to our customers. Our production processes are SOP-based and high-throughput, and have been streamlined to be exceptionally efficient on both a small and large scale. Each project is actively managed by a dedicated study director and a project manager to ensure timely completion with superior results that meet or exceed our clients’ expectations.